Compare RECT & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RECT | IRIX |
|---|---|---|
| Founded | 1997 | 1989 |
| Country | Singapore | United States |
| Employees | 111 | N/A |
| Industry | | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.6M | 25.6M |
| IPO Year | 2024 | 1996 |
| Metric | RECT | IRIX |
|---|---|---|
| Price | $1.59 | $1.45 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 5.8K | ★ 151.9K |
| Earning Date | 02-20-2026 | 11-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.12 | N/A |
| Revenue | $32,594,177.00 | ★ $50,647,000.00 |
| Revenue This Year | N/A | $9.61 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $13.17 | ★ N/A |
| Revenue Growth | ★ 5.91 | 4.58 |
| 52 Week Low | $1.30 | $0.78 |
| 52 Week High | $6.04 | $1.70 |
| Indicator | RECT | IRIX |
|---|---|---|
| Relative Strength Index (RSI) | 36.76 | 55.58 |
| Support Level | $1.51 | $1.36 |
| Resistance Level | $1.72 | $1.55 |
| Average True Range (ATR) | 0.14 | 0.12 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 41.67 | 26.84 |
Rectitude Holdings Ltd is principally involved in the provision of safety equipment, encompassing essential items such as personal protective clothing, hand gloves, safety footwear, and personal fall arrest systems (a system used to arrest an employee in a fall from a walking-working surface, usually consisting of a body harness, anchorage, and connector), portable fire extinguishers and traffic products such as rubber speed humps, wheel stops and wheel chocks. Additionally the company has added auxiliary products such as industrial hardware tools and electrical hardware required for construction sites.
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.